RecruitingNot ApplicableNCT05526534

A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms

A Randomized Controlled Trial on the Preventive Effect of Heated Humidified High Flow Nasal Cannula Oxygen Therapy on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms


Sponsor

Sichuan Cancer Hospital and Research Institute

Enrollment

200 participants

Start Date

Nov 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Patients at high risk of post-operative pulmonary complications (PPC) will be screened out from gynecological tumor patients undergoing surgical treatment, and randomly assigned into the HFNC group and control group, which uses conventional nasal cannula oxygen therapy. The primary outcome is the incidence of PPC, including postoperative hypoxemia, atelectasis, pneumonia, etc. Secondary outcomes are the improvement of postoperative oxygenation, antibiotic use, length of hospital stay, adverse events related to oxygen therapy, etc.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years

Inclusion Criteria6

  • Patients with gynecologic Neoplasms, including benign gynecologic tumors and malignant gynecologic tumors, who are 18 to 90 years old and are scheduled for surgical treatment in our center shall receive plain chest CT scan within 1 week before surgery, and the estimated surgical time shall be ≥2 hours, and at least one of the following conditions shall be met:
  • Assess respiratory risk in surgical patients in Catalonia (ARRSPC) ≥45 points;
  • BMI≥30;
  • Moderate to severe asthma;
  • Moderate to severe chronic obstructive pulmonary disease (COPD);
  • Smoking history ≥20 packs/year

Exclusion Criteria3

  • Patients with lung metastasis of malignant tumor or primary lung malignant tumor;
  • previous lung surgery or radiotherapy;
  • the surgery involved segmental bowel resection.

Interventions

DEVICEheated humidified high flow nasal cannula oxygen therapy, HFNC

HFNC can accurately provide 21% \~ 100% oxygen concentration through air oxygen mixer. And through the heating and humidification device to provide 37℃, relative humidity of 100% gas, the maximum flow of 70L/min.

DEVICENasal cannula oxygen

Nasal cannula oxygen has become a routine part of postoperative treatment


Locations(1)

Sichuan Cancer Hospital and Research Institute

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05526534


Related Trials